Can BTX-A and phenol or alcohol neurolysis therapies be combined?
• The primary reason for combining BTX-A with phenol or alcohol neurolysis therapies is to avoid resistance by remaining under the maximum dose per visit. • The decision to combine therapies usually depends on the location and number of target muscles involved. If both lower and upper extremities are to be injected, the combination of BTX-A and phenol may be warranted. • Although there are certain difficulties in using phenol or alcohol neurolysis, they provide inexpensive, long-term chemodenervation options for some patients. • Is BTX-A useful in treating pain? • Some patients with painful spasms or contracture report a reduction in pain after injection with BTX-A. • What are the chances of accidental overdose from BTX-A injections? (Unlikely) • Accidental overdose during spasticity therapy is highly improbable, since dozens more vials of BTX-A than are used therapeutically would need to be injected. In the event of an overdose, the medical information line maintained by Allergan can
